Splicing Interruption by Intron Variants in CSNK2B Causes Poirier-Bienvenu Neurodevelopmental Syndrome: A Focus on Genotype-Phenotype Correlations
- PMID: 35774559
- PMCID: PMC9237577
- DOI: 10.3389/fnins.2022.892768
Splicing Interruption by Intron Variants in CSNK2B Causes Poirier-Bienvenu Neurodevelopmental Syndrome: A Focus on Genotype-Phenotype Correlations
Abstract
CSNK2B has recently been identified as the causative gene for Poirier-Bienvenu neurodevelopmental syndrome (POBINDS). POBINDS is a rare neurodevelopmental disorder characterized by early-onset epilepsy, developmental delay, hypotonia, and dysmorphism. Limited by the scarcity of patients, the genotype-phenotype correlations in POBINDS are still unclear. In the present study, we describe the clinical and genetic characteristics of eight individuals with POBINDS, most of whom suffered developmental delay, generalized epilepsy, and hypotonia. Minigene experiments confirmed that two intron variants (c.367+5G>A and c.367+6T>C) resulted in the skipping of exon 5, leading to a premature termination of mRNA transcription. Combining our data with the available literature, the types of POBINDS-causing variants included missense, nonsense, frameshift, and splicing, but the variant types do not reflect the clinical severity. Reduced casein kinase 2 holoenzyme activity may represent a unifying pathogenesis. We also found that individuals with missense variants in the zinc finger domain had manageable seizures (p = 0.009) and milder intellectual disability (p = 0.003) than those with missense variants in other domains of CSNK2B. This is the first study of genotype-phenotype correlations in POBINDS, drawing attention to the pathogenicity of intron variants and expanding the understanding of neurodevelopmental disorders.
Keywords: CSNK2B; Poirier–Bienvenu neurodevelopmental syndrome; genotype; intron variants; phenotype.
Copyright © 2022 Zhang, Ye, Chen, Peng, Pang and Yin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Clinical and genetic analysis of six Chinese children with Poirier-Bienvenu neurodevelopmental syndrome caused by CSNK2B mutation.Neurogenetics. 2021 Oct;22(4):323-332. doi: 10.1007/s10048-021-00649-2. Epub 2021 Aug 9. Neurogenetics. 2021. PMID: 34370157
-
Genetic analysis and literature review of a Poirier-Bienvenu neurodevelopmental syndrome family line caused by a de novo frameshift variant in CSNK2B.Mol Genet Genomic Med. 2024 Jan;12(1):e2327. doi: 10.1002/mgg3.2327. Epub 2023 Nov 30. Mol Genet Genomic Med. 2024. PMID: 38037515 Free PMC article. Review.
-
Case report: Two cases of Poirier-Bienvenu neurodevelopmental syndrome and review of literature.Front Pediatr. 2023 Mar 20;11:967701. doi: 10.3389/fped.2023.967701. eCollection 2023. Front Pediatr. 2023. PMID: 37020656 Free PMC article.
-
Genetic analysis of four cases of Poirier Bienvenu neurodevelopmental syndrome associated with CSNK2B variant.BMC Med Genomics. 2025 Apr 10;18(1):68. doi: 10.1186/s12920-025-02132-5. BMC Med Genomics. 2025. PMID: 40211296 Free PMC article.
-
CSNK2B-Related Neurodevelopmental Disorder.2024 Sep 5. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. 2024 Sep 5. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 39236211 Free Books & Documents. Review.
Cited by
-
Haploinsufficiency as a Foreground Pathomechanism of Poirer-Bienvenu Syndrome and Novel Insights Underlying the Phenotypic Continuum of CSNK2B-Associated Disorders.Genes (Basel). 2023 Jan 18;14(2):250. doi: 10.3390/genes14020250. Genes (Basel). 2023. PMID: 36833176 Free PMC article.
-
CSNK2B Mutation: A Rare Cause of IGHD.Clin Endocrinol (Oxf). 2025 Apr;102(4):421-426. doi: 10.1111/cen.15174. Epub 2024 Dec 15. Clin Endocrinol (Oxf). 2025. PMID: 39676320 Free PMC article.
-
Casein Kinase 2 Affects Epilepsy by Regulating Ion Channels: A Potential Mechanism.CNS Neurol Disord Drug Targets. 2024;23(7):894-905. doi: 10.2174/1871527322666230622124618. CNS Neurol Disord Drug Targets. 2024. PMID: 37350003 Review.
-
Case report: Novel deletions in the 6p21.33 involving the CSNK2B gene in patients with Poirier-Bienvenu neurodevelopmental syndrome and literature review.Front Med (Lausanne). 2024 Oct 18;11:1441573. doi: 10.3389/fmed.2024.1441573. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39493709 Free PMC article.
References
-
- Bidwai A. P., Reed J. C., Glover C. V. (1995). Cloning and disruption of CKB1, the gene encoding the 38-kDa beta subunit of Saccharomyces cerevisiae casein kinase II (CKII). Deletion of CKII regulatory subunits elicits a salt-sensitive phenotype. J. Biol. Chem. 270 10395–10404. 10.1074/jbc.270.18.10395 - DOI - PubMed
LinkOut - more resources
Full Text Sources